Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Non-Current Assets (2020 - 2025)

Bio Essence has reported Non-Current Assets over the past 6 years, most recently at $97.0 for Q4 2025.

  • Quarterly results put Non-Current Assets at $97.0 for Q4 2025, down 70.78% from a year ago — trailing twelve months through Dec 2025 was $97.0 (down 70.78% YoY), and the annual figure for FY2025 was $97.0, down 70.78%.
  • Non-Current Assets for Q4 2025 was $97.0 at Bio Essence, down from $156.0 in the prior quarter.
  • Over the last five years, Non-Current Assets for BIOE hit a ceiling of $1.8 million in Q3 2023 and a floor of $97.0 in Q4 2025.
  • Median Non-Current Assets over the past 5 years was $1.3 million (2023), compared with a mean of $865912.8.
  • Biggest five-year swings in Non-Current Assets: soared 30.59% in 2023 and later tumbled 99.98% in 2025.
  • Bio Essence's Non-Current Assets stood at $1.4 million in 2021, then fell by 6.5% to $1.3 million in 2022, then plummeted by 84.5% to $208241.0 in 2023, then plummeted by 99.84% to $332.0 in 2024, then plummeted by 70.78% to $97.0 in 2025.
  • The last three reported values for Non-Current Assets were $97.0 (Q4 2025), $156.0 (Q3 2025), and $215.0 (Q2 2025) per Business Quant data.